We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+49.26%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.93B
AUM Growth
+$421M
Cap. Flow
-$64.9M
Cap. Flow %
-3.37%
Top 10 Hldgs %
81.87%
Holding
41
New
4
Increased
–
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
AKAO
Achaogen Inc
AKAO
+$16.4M
2
CASC
Cascadian Therapeutics, Inc.
CASC
+$12.2M
3
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$9.99M
4
AKTX
Akari Therapeutics
AKTX
+$7.28M

Top Sells

Rank Stock Value
1
OPWR
OPOWER INC COM STK (DE)
OPWR
+$61.3M
2
GRPN icon
Groupon
GRPN
+$40.9M
3
OREX
Orexigen Therapeutics, Inc.
OREX
+$1.51M
4
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$865K

Sector Composition

Rank Sector Weight
1 Healthcare 82.52%
2 Communication Services 5.59%
3 Consumer Discretionary 1.98%
4 Technology 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$864M 44.82%
10,275,113
– –
GRPN icon
2
Groupon
GRPN
$1.07B
$108M 5.59%
1,655,495
-553,153
-25% -$40.9M
SENS icon
3
Senseonics Holdings Inc
SENS
$258M
$103M 5.37%
1,315,159
– –
ARDX icon
4
Ardelyx
ARDX
$1.24B
$103M 5.34%
11,792,631
– –
DERM
5
DELISTED
Dermira, Inc.
DERM
$103M 5.32%
3,506,649
– –
ADAP
6
DELISTED
Adaptimmune Therapeutics
ADAP
$80.5M 4.18%
9,880,999
– –
EPZM
7
DELISTED
Epizyme, Inc
EPZM
$64.1M 3.33%
6,260,851
– –
CBIO
8
Crescent Biopharma
CBIO
$570M
$62.4M 3.24%
85,841
– –
NVRO
9
DELISTED
NEVRO CORP.
NVRO
$48.7M 2.53%
660,428
– –
LOXO
10
DELISTED
Loxo Oncology, Inc
LOXO
$41.5M 2.16%
1,792,207
– –
CRCM
11
DELISTED
CARE.COM, INC.
CRCM
$38.1M 1.98%
3,260,989
– –
KA
12
DELISTED
Kineta, Inc. Common Stock
KA
$37.5M 1.95%
22,109
– –
LXRX icon
13
Lexicon Pharmaceuticals
LXRX
$1.03B
$34.2M 1.77%
2,382,286
– –
ELGX
14
DELISTED
Endologix Inc
ELGX
$31M 1.61%
249,020
– –
HIVE
15
DELISTED
Aerohive Networks
HIVE
$31M 1.61%
4,681,455
– –
TRVN
16
DELISTED
Trevena, Inc.
TRVN
$24M 1.25%
6,099
– –
AKAO
17
DELISTED
Achaogen Inc
AKAO
$17.9M 0.93%
+4,715,128
New +$16.4M
EXEL icon
18
Exelixis
EXEL
$14B
$17.2M 0.89%
2,207,000
– –
CLVS
19
DELISTED
Clovis Oncology, Inc.
CLVS
$15.6M 0.81%
1,139,890
– –
SYBX
20
DELISTED
Synlogic
SYBX
$12.7M 0.66%
28,332
– –
CASC
21
DELISTED
Cascadian Therapeutics, Inc.
CASC
$10.1M 0.52%
+1,791,667
New +$12.2M
AVEO
22
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$9.95M 0.52%
+1,036,269
New +$9.99M
SBBP
23
DELISTED
Strongbridge Biopharma plc.
SBBP
$8.52M 0.44%
2,141,308
– –
TCON
24
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$8.28M 0.43%
9,448
– –
RIGL icon
25
Rigel Pharmaceuticals
RIGL
$715M
$7.23M 0.38%
324,315
– –
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.76B AUM 13.06% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return

NEA Management Company's Q2 2016 Portfolio in Review

As of Q2 2016, NEA Management Company held 41 positions worth $1.93B, up 28% from $1.51B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

NEA Management Company withdrew a net $64.9M in Q2 2016, closing 2 positions and reducing 3 holdings. Its most notable exit was OPOWER INC COM STK (DE), an estimated $61.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, up from 74% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, NEA Management Company opened a new position in Achaogen Inc worth $17.9M.

  • NEA Management Company's largest Q2 2016 buy was Achaogen Inc: 4,715,128 shares worth $17.9M.
  • NEA Management Company's biggest Q2 2016 reduction was Groupon, cutting an estimated $40.9M.
  • NEA Management Company fully exited OPOWER INC COM STK (DE) in Q2 2016, selling an estimated $61.3M.
  • NEA Management Company's ten largest holdings make up 82% of its $1.93B portfolio in Q2 2016.
  • NEA Management Company opened 4 new positions and closed 2 in Q2 2016.
  • NEA Management Company's portfolio value rose 28% quarter-over-quarter to $1.93B.

Based on NEA Management Company's 13F filing for Q2 2016, filed 5 Aug 2016.